LianBio logo

LianBio

NASDAQ:LIAN

Overview | Financials
Company Name LianBio
Symbol LIAN
Currency USD
Price 0.319
Market Cap 34,472,097
Dividend Yield 2,993.73%
52-week-range 0.241 - 4.99
Industry Biotechnology
Sector Healthcare
CEO Dr. Yizhe Wang Ph.D.
Website https://www.lianbio.com

An error occurred while fetching data.

About LianBio

LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex

Related Stocks

Zynex, Inc. logo

Zynex, Inc.

ZYXI

8 USD

Phathom Pharmaceuticals, Inc. logo

Phathom Pharmaceuticals, Inc.

PHAT

18.94 USD

Edgewise Therapeutics, Inc. logo

Edgewise Therapeutics, Inc.

EWTX

34.48 USD

Radius Health, Inc. logo

Radius Health, Inc.

RDUS

16.97 USD

Eiger BioPharmaceuticals, Inc. logo

Eiger BioPharmaceuticals, Inc.

EIGR

1.725 USD

Generation Bio Co. logo

Generation Bio Co.

GBIO

2.16 USD

Financials

Numbers are in millions USD

Numbers are in millions USD